Service agreement for panther fusion system.
Active Purchase Order Awarded Last action
- Contract number
- N3239822P0303
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $122,500
Award facts
- Opportunity
-
- N3239899Q1103 Solicitation number
- Contract value 100% obligated
- $122,500.00 Current and potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 561990 All Other Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $24,500 | |
| Exercise an Option | $24,500 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $24,500 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $24,500 | |
| Other Administrative Action | $0 | |
| Original award | $24,500 |
About this award
Gen-Probe Incorporated has been awarded a $122,500 firm fixed-price purchase order by the Department of the Navy Bureau of Medicine and Surgery for the exercise of Option Year 4 of a service agreement covering the PANTHER FUSION molecular diagnostic system (Serial Number 2090003912). The period of performance runs from May 20, 2026 through May 19, 2027, with the work to be performed in Silver Spring, Maryland. This contract was awarded without a set-aside designation, reflecting Gen-Probe's established position as a primary supplier of molecular diagnostic systems and services to the Department of Defense and other federal health agencies.
Gen-Probe Incorporated specializes in automated molecular diagnostic testing systems and related consumables, with its PANTHER and PANTHER FUSION platforms serving as critical infrastructure for high-throughput nucleic acid testing in clinical and military treatment facilities. The company maintains multiple indefinite delivery contracts and blanket purchase agreements with defense and civilian health agencies, including a $48.3 million ceiling contract with the Department of the Army Medical Command and a $9.6 million contract with the Navy Bureau of Medicine and Surgery for COVID-19 testing supplies and reagents. This Option Year 4 service agreement represents the continuation of ongoing maintenance and support services for an installed PANTHER FUSION system within the Navy's diagnostic laboratory network.
Quick answers
Who was awarded contract N3239822P0303?
N3239822P0303 was awarded to Gen-Probe Incorporated by Bureau of Medicine and Surgery (Department of the Navy) on May 18, 2022.
How much is contract N3239822P0303 worth?
The government has obligated $122,500 on N3239822P0303.
Was contract N3239822P0303 competed?
The extent of competition for N3239822P0303 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award